Vydura has been approved for use on the NHS in England, Scotland and Wales for treatment of an active migraine but only when other treatments have not worked.
Vydura has been also been approved by the NHS in England, Scotland and Wales for the prevention of migraine but only when at least 3 other preventative treatments have failed to work or cannot be taken.
This might be because current treatments for preventing migraine – including beta-blockers, antidepressants and epilepsy medications – can have significant side effects and do not work for everybody.
Rimegepant is the first oral drug from its class, Gepants, to be approved for migraine treatment in the UK.